Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients.
Camisaschi C, Renne SL, Beretta V, Rini F, Spagnuolo RD, Tuccitto A, Podda MG, Parmiani G, Rivoltini L, Collini P, Castelli C, Luksch R.
Camisaschi C, et al. Among authors: rini f.
BMC Cancer. 2018 Oct 16;18(1):983. doi: 10.1186/s12885-018-4910-8.
BMC Cancer. 2018.
PMID: 30326856
Free PMC article.
Clinical Trial.